9 completed, 4 unknown, 3 recruiting, 2 terminated. 4 Not applicable, 4 Phase 1, 4 Phase 2, 4 Phase 4, 1 Phase 3.
Follow Sir Charles Gairdner Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC) Triple Negative Breast Cancer (TNBC) | Not yet recruiting | Peter MacCallum Cancer Centre, Australia | 75 | 2026-04-08 | 2026-04-14 | |
| Treatable Traits in Interstitial Lung Disease Treatable traits model of care - Interstitial Lung Diseases (ILD) | Not applicable | Recruiting | The University of Western Australia | 110 | 2025-09-03 | 2025-10-07 |
| Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours Brain Tumours | Recruiting | The University of Western Australia | 100 | 2025-06-12 | 2025-06-19 | |
| A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) Dabrafenib 75 MG, Trametinib 2 MG - Thyroid Cancer | Phase 2 | Unknown | Olivia Newton-John Cancer Research Institute | 80 | 2022-07-14 | 2023-10-31 |
| Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease Intervention polysomnography, Sham polysomnography - Motor Neuron Disease / Amyotrophic Lateral Sclerosis | Not applicable | Recruiting | University of Melbourne | 244 | 2021-12-15 | 2022-06-23 |
| Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms Pipeline™ Flex Embolization Device with Shield Technology™ - Intracranial Aneurysm, Cerebral Aneurysm | Unknown | Gold Coast Hospital and Health Service | 500 | 2019-05-30 | 2019-12-10 | |
| AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion Pleurodesis via Video-assisted thoracoscopic surgery, Indwelling pleural catheter (with talc pleurodesis if suitable) - Malignant Pleural Effusion, Respiratory Disease | Not applicable | Completed | The University of Western Australia | 158 | 2018-05-29 | 2026-05-05 |
| Topical Magnesium and Muscle Cramps in Dialysis Patients. Transdermal Magnesium, Placebo - Chronic Kidney Diseases, End Stage Renal Disease | Phase 2 | Unknown | Sir Charles Gairdner Hospital | 40 | 2017-05-01 | 2017-03-17 |
| The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients Tissue Plasminogen Activator (tPA), recombinant deoxyribonuclease (DNase) - Peritoneal Dialysis, Peritoneal Dialysis, Continuous Ambulatory | Phase 1 | Terminated | Sir Charles Gairdner Hospital | 5 | 2016-01-01 | 2022-05-19 |
| Juno Perth Clinical Trial Juno - Respiratory Insufficiency, Obesity Hypoventilation Syndrome | Not applicable | Terminated | ResMed | 25 | 2015-05-29 | 2021-06-08 |
| Catheter Over Needle vs Catheter Through Needle E-Catheter (Pajunk), Sonolong Catheter (Pajunk) - Nerve Block, Catheterization | Phase 4 | Completed | Sir Charles Gairdner Hospital | 110 | 2015-05-01 | 2016-04-19 |
| Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome Deep brain stimulator ventral electrode up to 2 mA, Deep brain stimulator ventral electrode up to 3 mA, Deep brain stimulator dorsal electrode up to 2 mA - Tourette's Syndrome | Phase 1 / Phase 2 | Withdrawn | The University of Western Australia | 2013-03-01 | 2021-05-18 | |
| Midodrine for the Treatment of Refractory Hypotension Midodrine, Placebo - Hypotension, Critical Illness | Phase 3 | Completed | Massachusetts General Hospital | 139 | 2012-04-01 | 2020-10-28 |
| Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors Volitinib - Tumor | Phase 1 | Completed | Hutchison Medipharma Limited | 47 | 2012-02-01 | 2016-06-01 |
| An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease Mesenchymal stromal cells (MSC) for infusion - Crohn Disease | Phase 2 | Completed | R.P.Herrmann | 21 | 2010-01-01 | 2015-06-09 |
| Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis Exercise - Bronchiectasis | Phase 1 | Completed | Bayside Health | 39 | 2009-02-01 | 2014-03-11 |
| Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients Structured Exercise program, Cholecalciferol (25-Hydroxyvitamin D), Usual exercise - End Stage Kidney Disease | Phase 4 | Completed | Sir Charles Gairdner Hospital | 19 | 2009-01-01 | 2013-06-10 |
| Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients Eprex; Neorecormon; Aranesp - Kidney Failure, Chronic, Anemia | Completed | Sir Charles Gairdner Hospital | 150 | 2006-09-01 | 2008-05-23 | |
| Short Term Effects of FX Dialysers on QOL and Inflammation FX-class of dialyser - Kidney Failure, Chronic | Phase 4 | Completed | Sir Charles Gairdner Hospital | 50 | 2006-02-01 | 2007-04-25 |
| Thyroxine Titration Study Thyroxine - Hypothyroidism | Phase 4 | Unknown | Sir Charles Gairdner Hospital | 55 | 2003-04-01 | 2005-06-24 |
Kidney Failure, Chronic (4) · Inflammation (2) · Neoplasms (2) · Renal Insufficiency, Chronic (2) · Airway Obstruction (1) · Amyotrophic Lateral Sclerosis (1) · Anemia (1) · Brain Neoplasms (1) · Bronchiectasis (1) · Cerebral Hemorrhage (1) · Colitis (1) · Critical Illness (1) · Crohn Disease (1) · Hypotension (1) · Hypothyroidism (1)
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine (1) · 25-hydroxyvitamin D (1) · Cholecalciferol (1) · Darbepoetin alfa (1) · Epoetin Alfa (1) · Exercise (1) · Magnesium (1) · Midodrine (1) · Thyroxine (1) · Tissue Plasminogen Activator (1) · dabrafenib (1) · dornase alfa (1) · epoetin beta (1) · trametinib (1)
Australia (19) · United States (1)
Abbey Sawyer, PhD (1) · Andrew M Scott, MD, FRACP (1) · Anne-Marie Hill, PhD (1) · Annemarie L Lee, PhD (1) · Aron Chakera, DPhil (1) · Ben Bull (1) · Christopher Lind, FRACS (1) · Geoff Forbes, MD (1) · Hui Gan, MD,Ph.D (1) · Jason Lickliter, MD,Ph.D (1) · Matthias Eikermann, MD, PhD (1)
PMID 20122281, PMID 23872668, PMID 24731015, PMID 26252343, PMID 28327122, PMID 32956536, PMID 39762986, PMID 40050976